KIMS - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.9
| Stock Code | KIMS | Market Cap | 26,677 Cr. | Current Price | 667 ₹ | High / Low | 798 ₹ |
| Stock P/E | 95.2 | Book Value | 57.2 ₹ | Dividend Yield | 0.00 % | ROCE | 16.0 % |
| ROE | 14.0 % | Face Value | 2.00 ₹ | DMA 50 | 662 ₹ | DMA 200 | 663 ₹ |
| Chg in FII Hold | 0.24 % | Chg in DII Hold | -0.22 % | PAT Qtr | 72.5 Cr. | PAT Prev Qtr | 63.7 Cr. |
| RSI | 51.5 | MACD | 2.00 | Volume | 2,31,883 | Avg Vol 1Wk | 4,33,908 |
| Low price | 576 ₹ | High price | 798 ₹ | PEG Ratio | 317 | Debt to equity | 0.46 |
| 52w Index | 40.9 % | Qtr Profit Var | -5.23 % | EPS | 7.20 ₹ | Industry PE | 47.1 |
Analysis:
KIMS shows weak-to-moderate intraday strength with RSI at 51.5 and MACD mildly positive at 2.00. Current price (₹667) is hovering around both the 50 DMA (₹662) and 200 DMA (₹663), indicating indecisive momentum. Volume (2.31L) is significantly below the weekly average (4.33L), reflecting reduced trader participation. Valuations remain extremely stretched with a P/E of 95.2 compared to industry average of 47.1, limiting upside potential.
Optimal Buy Zone:
₹660 – ₹675 (near DMA support and current price action)
Exit Levels:
- Profit-taking: ₹690 – ₹705 (short-term resistance levels)
- Stop-loss: ₹650 (below DMA support and intraday pivot)
If Already Holding:
Exit intraday if price fails to sustain above ₹660 with declining volume or if RSI dips below 50. Book profits near ₹690–₹705 if momentum slows or volume fades.
---
Positive
- Strong ROCE (16%) and ROE (14%) support fundamentals
- EPS at ₹7.20 reflects earnings base
- Sequential PAT growth (₹72.5 Cr vs ₹63.7 Cr) shows improvement
- FII holdings increased (+0.24%), showing foreign investor confidence
Limitation
- Very high P/E (95.2) compared to industry average (47.1), suggesting premium valuation
- PEG ratio at 317 indicates extremely stretched growth-adjusted valuation
- Volume significantly below weekly average, limiting intraday strength
- Dividend yield at 0.00% provides no income support
Company Negative News
- Quarterly profit variation at -5.23% raises caution on earnings trajectory
- DII holdings decreased (-0.22%), showing reduced domestic institutional support
Company Positive News
- Sequential PAT growth supports earnings trajectory
- FII inflows indicate foreign investor confidence
- Stock trading near 52-week index gain of 40.9%, reflecting sector strength
Industry
- Industry P/E at 47.1, much lower than KIMS’s 95.2, suggesting premium pricing
- Sector momentum stable, with demand in healthcare services
Conclusion
KIMS is a cautious intraday candidate today with balanced momentum but stretched valuations and weak volume. Optimal buy near ₹660–₹675, profit exits around ₹690–₹705, and stop-loss at ₹650. Traders should monitor RSI and volume closely for intraday exit signals, as premium valuations may trigger quick reversals.
This modular HTML report captures KIMS’s intraday setup with clear entry/exit logic, positives, limitations, and sector overlays. Would you like me to add benchmarking against peers like Apollo Hospitals, Narayana Hrudayalaya, and Max Healthcare so you can compare intraday positioning across the healthcare sector?